Resveratrol (RSV) (3,4′,5 trihydroxystilbene) is a natural, non-flavonoid polyphenol widely present in the Mediterranean diet and, particularly, in grapes, peanuts, berries, and red wine.
Resveratrol (RSV) (3,4′,5 trihydroxystilbene) is a natural, non-flavonoid polyphenol widely present in the Mediterranean diet and, particularly, in grapes, peanuts, berries, and red wine [1,2]. However, its dietary intake is low, estimated to be only about 100 µg/day [3]. RSV is well absorbed, rapidly metabolized, and eliminated mainly through the urine [4]. This polyphenol belongs to dietary stilbenes, a class of natural compounds that have significant biological activities of medical interest. It derives from phenylalanine through the activation of the enzyme stilbene synthase and exists in two isomeric forms, trans- and cis-RSV [5], but the former is the most common.
RSV is a phytoalexin whose biological function is to protect plants from parasitic attack or environmental stress [6]. This molecule also has beneficial effects on human health. A recent review on clinical trials employing RSV has shown that it improves some clinical aspects in patients with obesity, malignancies (colorectal cancer and breast cancer), hypertension, Alzheimer’s disease, stroke, cardiovascular diseases, and diabetes mellitus [7]. Furthermore, clinical data suggest that RSV is safe even at high doses. Indeed, the administration of micronized RSV in patients with cancer did not lead to serious side effects [8]. Furthermore, it is associated with the “French paradox”. In the early 1990s, epidemiological data showed a low prevalence of coronary disease and, generally, a long life expectancy in French people despite a diet characterized by high saturated fat intake. This paradox was attributed to the moderate consumption of red wine with its anti-oxidative effects due to the high redox properties of phenolic hydroxyl groups, which act as free radical scavengers [9].
Although many studies have investigated the beneficial effects of RSV on experimental animals, there are few clinical trials in humans on the relationship between this compound and male fertility and the results are often controversial [10]. A recent review evaluated the impact of RSV on male and female reproduction, by analyzing studies both on human and animal models [10]. The authors concluded that, although a considerable amount of research supports the positive impact of RSV on human and animal reproduction, further studies are necessary to consolidate the knowledge on the properties of RSV and its role in reproductive functions.
Infertility is a widespread condition in industrialized countries where it affects up to 15% of couples of childbearing age [11]. It is defined as the inability to conceive after 1–2 years of unprotected sexual intercourse [12]. Male factor infertility accounts, cumulatively, for half of the couple’s infertility, being solely present in 30% of couples. Idiopathic male infertility is clinically diagnosed after excluding all other known causes of infertility and it affects up to 25% of patients [13].
Author and Year of Publication | Type of Study | Patients | Resveratrol Dose(s) Used | Duration of Resveratrol Administration | Main Findings |
---|---|---|---|---|---|
Collodel et al., 2011 [38] | In vitro | Non-reported | 6, 15, 30, 50, 100 µM | 60 min |
|
Nashtaei et al., 2016 [34] | In vitro | 22 donors with normozoospermia and proven fertility | 5, 15, 25 µM | 30 or 60 min |
|
Alamo et al., 2019 [41] | In vitro | 30 healthy men with normal sperm parameters | 15 µM/mL | 30 min |
|
Illiano et al., 2020 [14] | Prospective single-center clinical study (in vivo study) | 20 patients with oligozoospermia and/or asthenozoospermia | 150 mg every 12 h per os | Follow-up at 1, 3 and 6 months after treatment |
|
Branco et al., 2010 [45] | In vitro | 10 infertile patients and 10 healthy donors of proven fertility | 0.1, 1, 10 mM | Non-reported |
|
Garcez et al., 2010 [46] | In vitro prospective study | 20 infertile patients and 10 healthy donors of proven fertility | 0.1, 1, 10 mM | 60 min |
|
Meamar et al., 2012 [47] | In vitro prospective study | 21 donors with normozoospermia | 10, 100, 1000 µM | 3 days |
|
Li and al., 2018 [48] | In vitro | 50 donors with normozoospermia and 50 patients with OAT | 30 μmol/L | Non-reported |
|
Nashtaei et al., 2018 [49] | In vitro | 22 healthy volunteers with proven fertility | 15 µM | Non-reported |
|
Mohammadzadeh et al., 2020 [50] | In vitro | 10 donors with normozoospermia and 10 men with asthenozoospermia | 30 µmol/L | 60 min |
|
Cui et al., 2016 [51] | In vitro prospective case-control study | 60 obese patients | 2.6, 6, 15, 30, 50, 100 µmol/L | 30 min |
|
Cryopreservation is a routinely used procedure to store spermatozoa to be used in cycles of assisted reproductive techniques (ART) [52]. However, it damages a proportion of spermatozoa that do not survive thawing or have an alteration of their functional capacity. This is probably due to the excessive production of ROS and/or a reduced antioxidant capacity of the freezing medium, leading to increased oxidative stress [53]. For this reason, many studies have investigated whether RSV, thanks to its antioxidant effects, could counteract the effect of oxidative stress if added to semen samples before freezing.
In 2009, Branco and co-authors [45] evaluated the efficacy of RSV or ascorbic acid in preventing DNA damage induced by cryopreservation in spermatozoa of 10 infertile patients compared to 10 fertile controls. Specifically, before cryopreservation, each semen sample was divided into three aliquots: control, 10 mM of RSV, and 10 mM of acid ascorbic. The authors found that cryopreservation significantly increased DNA damage in all groups, although it was bigger in infertile patients, and ascorbic acid addition could prevent it only in the infertile group. On the contrary, RSV at a dose of 10 mM significantly decreased DNA damage in both groups of men studied, but it was not able to prevent the post-freezing motility decrease, so it was hypothesized that other factors apart from oxidative stress influenced post-cryopreservation motility reduction. Lower concentrations (0.1 and 1 mM) of RSV did not have significant effects on sperm DNA damage after freezing. The same authors got similar results in a subsequent study published in 2010 [46]. This study showed that RSV at different concentrations (0.1, 1, and 10 mM) was efficacious in preventing sperm lipid damage induced by cryopreservation in both fertile men and infertile patients in a dose-independent manner. On the contrary, the authors confirmed that RSV did not protect spermatozoa from losing motility [46].
Similar results were published by Meamar and collaborators [47]. These authors showed that the addition of RSV to the cryopreservation medium had different effects according to the concentration used. As suggested by previous studies, spermatozoa with DNA fragmentation were divided into two groups, based on the avidity for the nuclear probe propidium iodide (PI): PI brighter (PIbr), consisting of spermatozoa with partially fragmented DNA, and PIdimmer (PIdim), consisting of dead spermatozoa with entirely fragmented DNA. The authors after cryopreservation showed a statistically significant increase of sperm DNA fragmentation (SDF, evaluated by TUNEL assay) only in the PIbr population. In this population, RSV induced a slight, but significant decrease of post-thawing sperm DNA fragmentation levels compared to controls, at concentrations of 10 and 100 µM, without significantly affecting sperm motility or viability. Conversely, motility and viability were statistically significantly reduced when RSV was used at a concentration of 1 mM. These findings suggest that RSV at high concentrations also has toxic effects during cryopreservation, as shown on fresh semen samples [38]. The peculiarity of this study was that the protective effect of RSV was obtained at a much lower concentration than that used in previous studies (10 µM vs. 10 mM). However, the authors underlined that the effect of RSV (and other antioxidant substances used in their study) was very slight and it was not sufficient to completely prevent the damage induced by the cryopreservation process, suggesting other possible mechanisms involved in sperm damage, as an increase of apoptotic processes [47].
Li and collaborators published a study with opposite results [48]. They found that in comparison with the non-treated group, the post-thaw sperm cryopreserved with 30 μmol/L of RSV showed markedly higher progressively motile sperm, total motility, and viability.
RSV may improve cryopreserved sperm functions by activating 5′-AMPK. Shabani Nashtaei and co-authors [34] reported that AMPK is expressed in human fresh spermatozoa and it is mainly localized in the post-equatorial region of the sperm head and all along the entire flagellum. They incubated spermatozoa from normozoospermic donors for 30 or 60 min with different concentrations of Compound C (1, 10, 30 µM), an AMPK inhibitor, or RSV (5, 15, 25 µM), that acts as AMPK activator, as previously discussed. Subsequently, the semen samples were cryopreserved. The authors showed that RSV significantly increased AMPK phosphorylation and MMP, whereas it decreased ROS and apoptosis-like changes in frozen-thawed spermatozoa. Nevertheless, it was not able to compensate for the reduction in sperm viability and motility following cryopreservation. Opposite results were obtained with Compound C. Therefore, the authors hypothesized that RSV-induced improvement of cryopreserved sperm functions could be mediated through activation of AMPK. The same authors investigated the effect of 15 µM of RSV on sperm DNA integrity and fertilizing capacity by quantifying the presence of key paternal transcripts considered as potential markers for male fertility (protamine 1 (PRM1) and protamine 2(PRM2)) and pregnancy success (adducin 1 alpha (ADD1)) in cryopreserved human spermatozoa [49]. They showed that the addition of RSV to the freezing medium significantly decreased sperm DNA fragmentation compared with the control group. Furthermore, a statistically significant amelioration in terms of mRNA expression of PRM, PRM2, and ADD1 was found compared to controls. RSV-induced AMPK activation could be responsible for these effects since the use of Compound C (30 µM) induced opposite results. The authors hypothesized that stimulation of AMPK activity by RSV could stabilize the transcripts tested in this study by improving the interaction among mRNAs, making mRNA molecules more resistant to cryopreservation.
In 2020, the Iranian group of Mohammadzadeh and his collaborators published a study that tested the post-thawing effect of RSV directly on spermatozoa separated using the swim-up method [50]. Specifically, the samples were obtained by 10 normozoospermic men and 10 asthenozoospermic patients. After swim-up, spermatozoa were divided into two aliquots: the experimental one that was added with 30 μmol/L of RSV, and the control sample incubated without RSV. The authors found that, despite the protective effects on the semen samples after freezing, RSV did not significantly influence sperm parameters and chromatin quality in normozoospermic men and asthenozoospermic patients. However, they found a better sperm chromatin quality in the RSV treated group than in the control one, although this effect was more evident before freezing rather than after, likely due to the increased ROS production in the last condition. Therefore, the authors concluded that the results obtained in previous studies, conducted on whole semen samples, were in part affected by strong antioxidant compounds naturally contained in seminal fluid, which could better neutralize the effects of oxidative stress [50].
Cryopreservation is a routinely used procedure to store spermatozoa to be used in cycles of assisted reproductive techniques (ART) [52]. However, it damages a proportion of spermatozoa that do not survive thawing or have an alteration of their functional capacity. This is probably due to the excessive production of ROS and/or a reduced antioxidant capacity of the freezing medium, leading to increased oxidative stress [53]. For this reason, many studies have investigated whether RSV, thanks to its antioxidant effects, could counteract the effect of oxidative stress if added to semen samples before freezing.
In 2009, Branco and co-authors [45] evaluated the efficacy of RSV or ascorbic acid in preventing DNA damage induced by cryopreservation in spermatozoa of 10 infertile patients compared to 10 fertile controls. Specifically, before cryopreservation, each semen sample was divided into three aliquots: control, 10 mM of RSV, and 10 mM of acid ascorbic. The authors found that cryopreservation significantly increased DNA damage in all groups, although it was bigger in infertile patients, and ascorbic acid addition could prevent it only in the infertile group. On the contrary, RSV at a dose of 10 mM significantly decreased DNA damage in both groups of men studied, but it was not able to prevent the post-freezing motility decrease, so it was hypothesized that other factors apart from oxidative stress influenced post-cryopreservation motility reduction. Lower concentrations (0.1 and 1 mM) of RSV did not have significant effects on sperm DNA damage after freezing. The same authors got similar results in a subsequent study published in 2010 [46]. This study showed that RSV at different concentrations (0.1, 1, and 10 mM) was efficacious in preventing sperm lipid damage induced by cryopreservation in both fertile men and infertile patients in a dose-independent manner. On the contrary, the authors confirmed that RSV did not protect spermatozoa from losing motility [46].
Similar results were published by Meamar and collaborators [47]. These authors showed that the addition of RSV to the cryopreservation medium had different effects according to the concentration used. As suggested by previous studies, spermatozoa with DNA fragmentation were divided into two groups, based on the avidity for the nuclear probe propidium iodide (PI): PI brighter (PIbr), consisting of spermatozoa with partially fragmented DNA, and PIdimmer (PIdim), consisting of dead spermatozoa with entirely fragmented DNA. The authors after cryopreservation showed a statistically significant increase of sperm DNA fragmentation (SDF, evaluated by TUNEL assay) only in the PIbr population. In this population, RSV induced a slight, but significant decrease of post-thawing sperm DNA fragmentation levels compared to controls, at concentrations of 10 and 100 µM, without significantly affecting sperm motility or viability. Conversely, motility and viability were statistically significantly reduced when RSV was used at a concentration of 1 mM. These findings suggest that RSV at high concentrations also has toxic effects during cryopreservation, as shown on fresh semen samples [38]. The peculiarity of this study was that the protective effect of RSV was obtained at a much lower concentration than that used in previous studies (10 µM vs. 10 mM). However, the authors underlined that the effect of RSV (and other antioxidant substances used in their study) was very slight and it was not sufficient to completely prevent the damage induced by the cryopreservation process, suggesting other possible mechanisms involved in sperm damage, as an increase of apoptotic processes [47].
Li and collaborators published a study with opposite results [48]. They found that in comparison with the non-treated group, the post-thaw sperm cryopreserved with 30 μmol/L of RSV showed markedly higher progressively motile sperm, total motility, and viability.
RSV may improve cryopreserved sperm functions by activating 5′-AMPK. Shabani Nashtaei and co-authors [34] reported that AMPK is expressed in human fresh spermatozoa and it is mainly localized in the post-equatorial region of the sperm head and all along the entire flagellum. They incubated spermatozoa from normozoospermic donors for 30 or 60 min with different concentrations of Compound C (1, 10, 30 µM), an AMPK inhibitor, or RSV (5, 15, 25 µM), that acts as AMPK activator, as previously discussed. Subsequently, the semen samples were cryopreserved. The authors showed that RSV significantly increased AMPK phosphorylation and MMP, whereas it decreased ROS and apoptosis-like changes in frozen-thawed spermatozoa. Nevertheless, it was not able to compensate for the reduction in sperm viability and motility following cryopreservation. Opposite results were obtained with Compound C. Therefore, the authors hypothesized that RSV-induced improvement of cryopreserved sperm functions could be mediated through activation of AMPK. The same authors investigated the effect of 15 µM of RSV on sperm DNA integrity and fertilizing capacity by quantifying the presence of key paternal transcripts considered as potential markers for male fertility (protamine 1 (PRM1) and protamine 2(PRM2)) and pregnancy success (adducin 1 alpha (ADD1)) in cryopreserved human spermatozoa [49]. They showed that the addition of RSV to the freezing medium significantly decreased sperm DNA fragmentation compared with the control group. Furthermore, a statistically significant amelioration in terms of mRNA expression of PRM, PRM2, and ADD1 was found compared to controls. RSV-induced AMPK activation could be responsible for these effects since the use of Compound C (30 µM) induced opposite results. The authors hypothesized that stimulation of AMPK activity by RSV could stabilize the transcripts tested in this study by improving the interaction among mRNAs, making mRNA molecules more resistant to cryopreservation.
In 2020, the Iranian group of Mohammadzadeh and his collaborators published a study that tested the post-thawing effect of RSV directly on spermatozoa separated using the swim-up method [50]. Specifically, the samples were obtained by 10 normozoospermic men and 10 asthenozoospermic patients. After swim-up, spermatozoa were divided into two aliquots: the experimental one that was added with 30 μmol/L of RSV, and the control sample incubated without RSV. The authors found that, despite the protective effects on the semen samples after freezing, RSV did not significantly influence sperm parameters and chromatin quality in normozoospermic men and asthenozoospermic patients. However, they found a better sperm chromatin quality in the RSV treated group than in the control one, although this effect was more evident before freezing rather than after, likely due to the increased ROS production in the last condition. Therefore, the authors concluded that the results obtained in previous studies, conducted on whole semen samples, were in part affected by strong antioxidant compounds naturally contained in seminal fluid, which could better neutralize the effects of oxidative stress [50].
Table 1 summarizes the principal studies evaluating the effects of RSV on sperm cryopreservation.
Animal models [54,55,56] suggest that RSV could have a protective role in sperm function in obese men. Overweight and obesity, in fact, have been shown to increase the risk of developing reproductive disorders [54,57]. Many studies studied have shown that sperm quality is significantly affected by overweight, in terms of decreased sperm concentration and total motile sperm count [54,55,56].
Many preclinical studies have reported that RSV improves glucose metabolism and homeostasis, thus, suggesting its possible use as a therapeutic strategy in the fight against obesity [35]. However, data from human studies are still scarce and, at times, contradictory and inconclusive. Based on these data, it can be hypothesized that RSV may be effective for the treatment of infertility in obese males.
Cui and collaborators [51] incubated 60 semen samples obtained from obese and asthenozoospermic patients with 0–100 µM RSV for 30 min and observed various degrees of improvement in sperm motility. Among the various concentrations of RSV tested in this study, 30 µM/L was associated with the most significant improvement in sperm motility when compared with controls. The authors also evaluated the effect of this concentration of RSV on seminal plasma zinc concentration and spermatozoa acrosin activity. The RSV-treated group showed a significantly increased seminal plasma zinc concentration and sperm acrosin activity compared with the control group. They concluded that RSV could have therapeutic and protective effects against obesity-induced semen and sperm parameter abnormalities (Table 1) [51]. To the best of our knowledge, this is the only study conducted on human spermatozoa so far, while many studies have been conducted on animal models [58,59]. Therefore, further studies will be needed to evaluate the effective efficacy of RSV in this selected category of patients.
This entry is adapted from the peer-reviewed paper 10.3390/molecules26092495